Georgios Gakis
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Urological Disorders and Treatments
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Urinary Bladder and Prostate Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Urologic and reproductive health conditions
- Cancer, Lipids, and Metabolism
- Genital Health and Disease
- Urinary Tract Infections Management
- Ureteral procedures and complications
- Esophageal Cancer Research and Treatment
- Pediatric Urology and Nephrology Studies
- Inflammatory Biomarkers in Disease Prognosis
- Pelvic floor disorders treatments
- Renal and related cancers
- Testicular diseases and treatments
- Bone health and treatments
- Tissue Engineering and Regenerative Medicine
- Cancer Genomics and Diagnostics
- Sarcoma Diagnosis and Treatment
- Epigenetics and DNA Methylation
- Medical and Health Sciences Research
Klinik und Poliklinik für Urologie
2015-2024
Martin Luther University Halle-Wittenberg
2023-2024
University of Würzburg
2017-2024
University Hospital in Halle
2023-2024
LMU Klinikum
2024
Ludwig-Maximilians-Universität München
2009-2024
Universitätsklinikum Würzburg
2017-2023
University Children's Hospital Tübingen
2011-2022
Friedrich-Alexander-Universität Erlangen-Nürnberg
2021
University of Tübingen
2009-2019
Abstract Background The study aim was to investigate potential influences on human nerves and pelvic organs through early implantation of bilateral sacral nerve modulators (SNMs) in complete spinal cord injury (SCI) patients during the acute bladder‐areflexia phase. Methods Ten with neurologically‐confirmed lesions (SCLs) were provided SNMs phase atonic‐detrusor muscle. Modulation achieved by two electrodes implanted into each S 3 ‐foramen. Six declined served as controls. mean follow‐up...
The highly frequent strategy of surveillance for non–muscle-invasive bladder cancer (NMIBC) involves cystoscopy and cytology. Urine assays currently available have not shown performance sufficient to replace the current gold standard follow-up, which would require a very high negative predictive value (NPV), especially high-grade tumors. Bladder EpiCheck (BE) is novel urine assay that uses 15 proprietary DNA methylation biomarkers assess presence cancer. To BE NMIBC recurrence. This was...
Study Type – Prognosis (case series) Level of Evidence 4 What’s known on the subject? and What does study add? There is increasing evidence for a prognostic significance pretherapeutically elevated serum C‐reactive protein levels in various cancers. However, little about its patients with invasive bladder cancer. This shows that CRP an independent predictor cancer‐specific survival cancer, incorporation into new outcome model (TNR‐C Score) encompassing major pathological determinants...